IC
AZN icon

Inscription Capital’s AstraZeneca AZN Stock Holding History

Inscription Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$347K Buy
1,832
+654
+56% +$123K 0.03% 502
2026
Q1 		$232K Sell
1,178
-907
-44% -$175K 0.02% 569
2025
Q4 		$383K Buy
2,085
+22
+1% +$3.86K 0.04% 433
2025
Q3 		$316K Buy
+2,063
New +$312K 0.03% 473
2025
Q2 		– Sell
-6,642
Closed -$900K – 491
2025
Q1 		$900K Buy
+6,642
New +$961K 0.15% 113
2024
Q3 		$936K Sell
6,008
-162
-3% -$26.1K 0.14% 115
2024
Q2 		$962K Sell
6,170
-472
-7% -$71K 0.15% 105
2024
Q1 		$900K Buy
6,642
+3,778
+132% +$500K 0.15% 113
2023
Q4 		$386K Hold
2,864
– – 0.11% 143
2023
Q3 		$388K Sell
2,864
-800
-22% -$109K 0.13% 124
2023
Q2 		$524K Hold
3,664
– – 0.16% 101
2023
Q1 		$509K Sell
3,664
-272
-7% -$36.6K 0.13% 116
2022
Q4 		$534K Sell
3,936
-25
-0.6% -$3.13K 0.18% 101
2022
Q3 		$434K Buy
3,961
+270
+7% +$34.3K 0.12% 118
2022
Q2 		$488K Buy
3,691
+900
+32% +$118K 0.09% 157
2022
Q1 		$370K Hold
2,791
– – 0.11% 144
2021
Q4 		$325K Sell
2,791
-50
-2% -$5.88K 0.09% 167
2021
Q3 		$341K Buy
+2,841
New +$331K 0.11% 156
2021
Q2 		– Sell
-2,891
Closed -$287K – 317
2021
Q1 		$287K Buy
+2,891
New +$291K 0.1% 157

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Inscription Capital's AZN Position: Q2 2026 in Review

Inscription Capital increased its AstraZeneca (AZN) stake by 56% in Q2 2026, buying an estimated $123K and bringing the position to 1,832 shares worth $347K. The position accounts for 0.03% of the portfolio, ranked #502.

Inscription Capital first reported a position in AZN in Q1 2021 and has held it in 19 quarters since. The position peaked at $962K in Q2 2024. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Inscription Capital held 1,832 shares of AstraZeneca worth $347K as of Q2 2026.
  • Inscription Capital bought 654 AstraZeneca shares in Q2 2026, an estimated $123K.
  • AstraZeneca made up 0.03% of Inscription Capital's portfolio in Q2 2026, its #502 holding.
  • Inscription Capital first reported a position in AstraZeneca in Q1 2021 and has held it in 19 quarters since.
  • Inscription Capital's AstraZeneca position peaked at $962K in Q2 2024.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.